Substance P

From Pain to Cancer
Herausgeber: Vink, Robert

• Broschiertes Buch

Produktbeschreibung

Substance P: From Pain to Cancer, a volume in the Molecular Mediators in Health and Disease: How Cells Communicate series, provides a complete discussion of substance P biology, its role in normal physiology and a variety of diseases. The volume provides an introduction to substance P and its pharmacology, followed by exploring its role across the human body including cardiovascular function, micturition, learning and memory, emesis, respiration and sleep. It then discusses the critical role of substance P in several disease states including acute brain injury, neurodegeneration, seizures, depression and anxiety, cancer, musculoskeletal disorders, and viral infection, including COVID-19. The book closes with a look towards future perspectives for substance P. Substance P: From Pain to Cancer is an ideal reference for researchers across the life sciences interested in understanding the role of this multi-functioning mediator and its biological significance.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 550
• Erscheinungstermin: 8. November 2024
• Englisch
• Gewicht: 450g
• ISBN-13: 9780443221941
• ISBN-10: 0443221944
• Artikelnr.: 71266339

Inhaltsangabe

1. The synthesis, release, and binding of substance P Brendan A. Hilliard,
Robert Vink, and Mary F. Barbe 2. Distribution of substance P receptors in
mammals Honoo Satake, Akira Shiraishi, and Tsuyoshi Kawada 3. Substance P
in nonmammalian biology: Evolutionarily conserved tachykinin signaling Dick
R. Nassel 4. Methodological foundations of substance P detection Nuray Erin
5. Substance P receptor antagonists Francisco D. Rodr¿guez and Rafael
Covenas 6. Substance P in the cardiovascular system Magdalena Chottova
Dvorakova and Shashank Pandey 7. Substance P in lower urinary tract
function and dysfunction Mitsuharu Yoshiyama 8. Role of the substance P in
learning and memory Natalia Favila and Paul G. Overton 9. Substance P in
nausea and vomiting Paul L.R. Andrews, John A. Rudd, and Gareth J. Sanger
10. Substance P in the central control of respiration Nicholas J. Burgraff
and Jan-Marino Ramirez 11. Substance P in bone metabolism Tanja Niedermair
and Susanne Grassel 12. Life without substance P: The naked mole rat Aishi
Zhao, Jiwon Lee, Weronika Gryszkiewicz, and Thomas J. Park 13. Substance P
in inflammation Sophie E. Sipprell and Ian Marriott 14. Substance P in
oxidative stress Seyed Isaac Hashemy and Safieh Ebrahimi 15. Substance P in
pain Robert Vink 16. Substance P in cancer Miguel Munoz, Marisa Rosso,
Riffat Mehboob, and Francisco Esteban 17. Substance P in cardiac
dysfunction Scott P. Levick and Alexander Widiapradja 18. Substance P in
neurotrauma Rebecca George, Justin Krieg, and Frances Corrigan 19.
Substance P in stroke Annabel Sorby-Adams 20. Substance P in Alzheimer’s
and Parkinson’s disease Severini Cinzia 21. Substance P receptor
antagonists for major depressive disorder Nadia M.J. Rupniak and Mark S.
Kramer 22 From a putative antidepressant to a validated mouse model of ADHD
via NK1 receptors S.C. Stanford 23. Substance P in stress and anxiety Karl
Ebner and Nicolas Singewald 24. Substance P-neurokinin 1 receptor pathway
in musculoskeletal disorders Brendan A. Hilliard and Mary F. Barbe 25.
Substance P and sudden infant death syndrome (SIDS) F. Bright, Robert Vink,
and R.W. Byard 26. Immunobiology and pharmacology of neuropeptide substance
P Ehsan Aslam, Asina Gijasi, Caroline Perner, Rob van Wijk, Anne-Grete
Martson, Gerard J.P. van Westen, Ilze Bot, Laura H. Heitman, and Alireza
Mashaghi 27. Substance P in viral diseases-Especially coronavirus disease
Riffat Mehboob, Mariam Hashim, and Miguel Munoz 28. Substance P:
Perspectives and future directions Robert Vink